Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Treacle and smallpox : two tests for multi-criteria decision analysis models in health technology assessment

Morton, Alec (2017) Treacle and smallpox : two tests for multi-criteria decision analysis models in health technology assessment. Value in Health, 30 (3). pp. 512-515. ISSN 1524-4733

[img]
Preview
Text (Morton-VH-2016-two-tests-for-multi-criteria-decision-analysis-models-in-health-technology-assessment)
Morton_VH_2016_two_tests_for_multi_criteria_decision_analysis_models_in_health_technology_assessment.pdf
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (475kB) | Preview

Abstract

Multicriteria Decision Analysis (MCDA) is, rightly, receiving increasing attention in Health Technology Assessment. However, a distinguishing feature of the health domain is that technologies must actually improve health, and good performance on other criteria cannot compensate for failure to do so. We argue for two reasonable tests for MCDA models: the treacle test (can a winning intervention be incompletely ineffective?) and the smallpox test (can a winning intervention be for a disease which no one suffers from?). We explore why models might fail such tests (as the models of some existing published studies would do) and offer some suggestions as to how practice should be improved.